Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

522 trials

NCT06833073
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Phase 2 · Argentina, Australia, Brazil, Canada, Chile, Colombia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hungary, Italy, Netherlands, Peru, Poland, Thailand, United States · 89 sites
Registry update: 1 Oct 2026
NCT06778863
Recruiting
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Phase 1 · United States · 21 sites
Registry update: 13 Feb 2026
NCT06503614
Recruiting
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer
Phase 2 · United States · 5 sites
Registry update: 5 Oct 2026
NCT06696794
Recruiting
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
Phase 3 · China · 3 sites
Registry update: 19 Feb 2025
NCT06760819
Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Phase 2 · Australia, Canada, Switzerland, China, Denmark, Spain, France, Italy, Japan, South Korea, United States · 54 sites
Registry update: 4 Nov 2026
NCT06738251
Recruiting
A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma
Phase 3 · China · 1 site
Registry update: 17 Jul 2025
NCT06763354
Recruiting
The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging
Not applicable · China · 1 site
Registry update: 14 Mar 2025
NCT06337942
Recruiting
Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study
Not applicable · United States · 1 site
Registry update: 12 Feb 2025
NCT07036731
Recruiting
A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing
Not applicable · China · 1 site
Registry update: 25 Jun 2025
NCT06657157
Recruiting
Peripheral Neuropathy in Patients Receiving Enfortumab Vedotin and Pembrolizumab as First Line Treatment for Metastatic or Locally Advanced Urothelial Carcinoma
Not applicable · Germany · 4 sites
Registry update: 24 Feb 2026
NCT06721260
Recruiting
Metabolism Evaluation Through Resting Indirect Calorimetry in Bladder Cancer (METRICS)
Not applicable · United States · 1 site
Registry update: 20 Mar 2026
NCT06823427
Recruiting
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 · China · 2 sites
Registry update: 21 Mar 2025
NCT06972771
Recruiting
Trop2-targeting NIR-II Molecular Probe for Guided Identification of Non-Muscle-Invasive Bladder Cancer
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT06493370
Recruiting
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
Phase 2 · United States · 2 sites
Registry update: 20 Feb 2025
NCT06891209
Recruiting
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
Not applicable · United States · 1 site
Registry update: 11 Aug 2026
NCT06695845
Recruiting
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 · Spain, Georgia, South Korea, United States · 42 sites
Registry update: 4 Nov 2026
NCT06766266
Recruiting
Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment
Phase 1 · China · 1 site
Registry update: 26 Mar 2025
NCT06605404
Recruiting
Pan-tumor MRD Study
Not applicable · United States · 47 sites
Registry update: 24 Sept 2026
NCT06764095
Recruiting
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
Phase 4 · United States · 1 site
Registry update: 1 Oct 2026
NCT06709196
Recruiting
Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis
Phase 4 · Denmark · 5 sites
Registry update: 9 Jan 2025

Ordered by registry start date. Freshness and sponsorship never change the order.